GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Asset Turnover

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Asset Turnover : 0.12 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. JSP Pharmaceutical Manufacturing (Thailand) PCL's Revenue for the three months ended in Mar. 2024 was ฿155.66 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Assets for the quarter that ended in Mar. 2024 was ฿1,353.69 Mil. Therefore, JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover for the quarter that ended in Mar. 2024 was 0.12.

Asset Turnover is linked to ROE % through Du Pont Formula. JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized ROE % for the quarter that ended in Mar. 2024 was -1.14%. It is also linked to ROA % through Du Pont Formula. JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized ROA % for the quarter that ended in Mar. 2024 was -0.73%.


JSP Pharmaceutical Manufacturing (Thailand) PCL Asset Turnover Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Asset Turnover Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
0.82 0.98 0.48 0.35 0.43

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.13 0.12 0.12

Competitive Comparison of JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover

For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover distribution charts can be found below:

* The bar in red indicates where JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover falls into.



JSP Pharmaceutical Manufacturing (Thailand) PCL Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=575.578/( (1366.512+1335.675)/ 2 )
=575.578/1351.0935
=0.43

JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=155.661/( (1335.675+1371.711)/ 2 )
=155.661/1353.693
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP-F) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

JSP Pharmaceutical Manufacturing (Thailand) PCL's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-9.86/868.604
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-9.86 / 622.644)*(622.644 / 1353.693)*(1353.693/ 868.604)
=Net Margin %*Asset Turnover*Equity Multiplier
=-1.58 %*0.46*1.5585
=ROA %*Equity Multiplier
=-0.73 %*1.5585
=-1.14 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

JSP Pharmaceutical Manufacturing (Thailand) PCL's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-9.86/1353.693
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-9.86 / 622.644)*(622.644 / 1353.693)
=Net Margin %*Asset Turnover
=-1.58 %*0.46
=-0.73 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


JSP Pharmaceutical Manufacturing (Thailand) PCL Asset Turnover Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines